-
1
-
-
77953950024
-
Genetic disorders of renal phosphate transport
-
Prie D., Friedlander G. Genetic disorders of renal phosphate transport. N Engl J Med 2010, 362:2399-2409.
-
(2010)
N Engl J Med
, vol.362
, pp. 2399-2409
-
-
Prie, D.1
Friedlander, G.2
-
2
-
-
79952760461
-
Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease
-
Filler G., Liu D., Huang S.H., Casier S., Chau L.A., Madrenas J. Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease. Clin Biochem 2011, 44:435-437.
-
(2011)
Clin Biochem
, vol.44
, pp. 435-437
-
-
Filler, G.1
Liu, D.2
Huang, S.H.3
Casier, S.4
Chau, L.A.5
Madrenas, J.6
-
3
-
-
14944360740
-
Octreotide therapy for tumor-induced osteomalacia
-
Seufert J., Ebert K., Muller J., et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 2001, 345:1883-1888.
-
(2001)
N Engl J Med
, vol.345
, pp. 1883-1888
-
-
Seufert, J.1
Ebert, K.2
Muller, J.3
-
4
-
-
70350707962
-
Resolution of severe oncogenic hypophosphatemic osteomalacia after resection of a deeply located soft-tissue tumour
-
Radaideh A.R., Jaradat D., Abu-Kalaf M.M., Nusier M.K. Resolution of severe oncogenic hypophosphatemic osteomalacia after resection of a deeply located soft-tissue tumour. Curr Oncol 2009, 16:87-90.
-
(2009)
Curr Oncol
, vol.16
, pp. 87-90
-
-
Radaideh, A.R.1
Jaradat, D.2
Abu-Kalaf, M.M.3
Nusier, M.K.4
-
5
-
-
38949151685
-
Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1
-
Hannan F.M., Athanasou N.A., Teh J., Gibbons C.L., Shine B., Thakker R.V. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1. Eur J Endocrinol 2008, 158:265-271.
-
(2008)
Eur J Endocrinol
, vol.158
, pp. 265-271
-
-
Hannan, F.M.1
Athanasou, N.A.2
Teh, J.3
Gibbons, C.L.4
Shine, B.5
Thakker, R.V.6
-
6
-
-
15544385175
-
Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case
-
Dupond J.L., Mahammedi H., Prie D., et al. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case. Bone 2005, 36:375-378.
-
(2005)
Bone
, vol.36
, pp. 375-378
-
-
Dupond, J.L.1
Mahammedi, H.2
Prie, D.3
-
7
-
-
4043052503
-
Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia
-
Takeuchi Y., Suzuki H., Ogura S., et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 2004, 89:3979-3982.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 3979-3982
-
-
Takeuchi, Y.1
Suzuki, H.2
Ogura, S.3
-
8
-
-
40949151916
-
Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling
-
van Boekel G., Ruinemans-Koerts J., Joosten F., Dijkhuizen P., van Sorge A., de Boer H. Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling. Eur J Endocrinol 2008, 158:431-437.
-
(2008)
Eur J Endocrinol
, vol.158
, pp. 431-437
-
-
van Boekel, G.1
Ruinemans-Koerts, J.2
Joosten, F.3
Dijkhuizen, P.4
van Sorge, A.5
de Boer, H.6
-
9
-
-
79958866008
-
Selective venous catheterization for the localization of phosphaturic mesenchymal tumors
-
Andreopoulou P., Dumitrescu C.E., Kelly M.H., et al. Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res 2011, 26:1295-1302.
-
(2011)
J Bone Miner Res
, vol.26
, pp. 1295-1302
-
-
Andreopoulou, P.1
Dumitrescu, C.E.2
Kelly, M.H.3
-
10
-
-
1842685810
-
Usefulness of 201Tl and 99mTc MIBI scintigraphy in a case of oncogenic osteomalacia
-
Kimizuka T., Ozaki Y., Sumi Y. Usefulness of 201Tl and 99mTc MIBI scintigraphy in a case of oncogenic osteomalacia. Ann Nucl Med 2004, 18:63-67.
-
(2004)
Ann Nucl Med
, vol.18
, pp. 63-67
-
-
Kimizuka, T.1
Ozaki, Y.2
Sumi, Y.3
-
11
-
-
33845964211
-
Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography
-
Hesse E., Moessinger E., Rosenthal H., et al. Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography. J Bone Miner Res 2007, 22:158-162.
-
(2007)
J Bone Miner Res
, vol.22
, pp. 158-162
-
-
Hesse, E.1
Moessinger, E.2
Rosenthal, H.3
-
12
-
-
0028276322
-
Dipyridamole for renal phosphate leak?
-
Michaut P., Prie D., Amiel C., Friedlander G. Dipyridamole for renal phosphate leak?. N Engl J Med 1994, 331:58-59.
-
(1994)
N Engl J Med
, vol.331
, pp. 58-59
-
-
Michaut, P.1
Prie, D.2
Amiel, C.3
Friedlander, G.4
-
13
-
-
34548219092
-
Cinacalcet in the management of tumor-induced osteomalacia
-
Geller J.L., Khosravi A., Kelly M.H., Riminucci M., Adams J.S., Collins M.T. Cinacalcet in the management of tumor-induced osteomalacia. J Bone Miner Res 2007, 22:931-937.
-
(2007)
J Bone Miner Res
, vol.22
, pp. 931-937
-
-
Geller, J.L.1
Khosravi, A.2
Kelly, M.H.3
Riminucci, M.4
Adams, J.S.5
Collins, M.T.6
|